People · Operator
Named in public records as an officer, director or promoter · active 2016–2024 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nivati, Inc. | — | Other Health Care | Seed | $4.5M | $2.4M | 2024 |
| Canopy Biosciences, LLC | — | Biotechnology | Seed | $3.2M | $92.1M | 2016 |
David Kingsley at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Kingsley on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Charles Bolten | 1 | 10 |
| Chris Marks | 1 | 8 |
| Brian Wallace | 1 | 8 |
| David Smoller | 1 | 6 |
| Edward Weinstein | 1 | 3 |
| Cydni Tetro | 1 | 2 |
| Crystal Winkeler | 1 | 2 |
| Adam Slovik | 1 | 2 |
| Dan Tyre | 1 | 1 |
| Cyndi Tetro | 1 | 1 |
| Amelia Wilcox | 1 | 1 |
| Pamela Stevenson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.